| Summary |
|
|||||||||||||
|
Transgene origin |
|
|||||||||||||
|
Transgene description |
|
|||||||||||||
| Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||
| Disease models |
|
|||||||||||||
| Expression |
|
|||||||||||||
| Find Mice (IMSR) |
|
|||||||||||||
| Notes |
Founder 120 is representative of 2 founders carrying 2 and 3 copies of the transgene. These animals express approximately 50% the amount of endogenous mRNA and exhibit neurological anomalies at 6 months of age.
The phenotype is more severe in homozygous mice verses hemizygous mice, implying a correlation between phenotype and expression levels of NEFH. |
|||||||||||||
| References |
|
|||||||||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||